Our scientific expertise includes mechanisms and targets that underpin chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, systemic sclerosis and asthma.
Scientists in our dedicated respiratory research and development centers, located in the USA and Germany, have extensive R&D expertise in the discovery and clinical validation of novel mechanisms of action. Together with our academic and industry partners, they are working to offer patients and doctors new therapeutic options to treat chronic inflammatory and fibrotic diseases of the lungs.
